BioRestorative Therapies (NASDAQ:BRTX) stock is taking off on Thursday following news that the medical company is in negotiations with an undisclosed commercial-stage regenerative medicine company.
These negotiations cover a potential license for BioRestorative’s ThermoStem metabolic intellectual property. The company says the discussions are “substantive” but can’t confirm they will lead to a deal. It also won’t announce any further details until it signs an agreement.
BioRestorative Therapies CEO Lance Alstodt said the following about this news:
“We are particularly pleased that our pioneering animal studies, which demonstrated that BADSCs show promise in correcting the weight gain and hyperglycemia associated with high fat feeding, and that our 3D scaffolds, which are capable of retaining viable transplanted cells for at least five weeks post-implantation, have attracted the caliber of commercial stage regenerative medicine company with which we are now engaged in substantive licensing discussions.”
BRTX Stock Movement Today
Investors are excited about the company’s potential deal and that brings with it heavy trading of BRTX stock. This has more than 78 million shares on the move as investors buy the stock. To put that in perspective, BioRestorative Therapies’ daily average trading volume is well below that at 544,000 shares.
BRTX stock is up 42.3% as of Thursday morning.
Investors will want to keep reading for more of the most recent stock market news!
We have all of the hottest stock market stories available on Thursday! Among that is what has shares of Workhorse (NASDAQ:WKHS), Williams-Sonoma (NYSE:WSM) and Broadcom (NASDAQ:AVGO) stock moving today. All of that info is ready to go at the links below!
More Stock Market News for Thursday
- Workhorse (WKHS) Stock Plunges 11% on 1-for-20 Reverse Stock Split
- Williams-Sonoma Stock Split: Mark Your Calendars for June 27
- Broadcom (AVGO) Stock Surges as Latest Winner in AI Frenzy
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
